BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 33934807)

  • 1. Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles.
    Gimona M; Brizzi MF; Choo ABH; Dominici M; Davidson SM; Grillari J; Hermann DM; Hill AF; de Kleijn D; Lai RC; Lai CP; Lim R; Monguió-Tortajada M; Muraca M; Ochiya T; Ortiz LA; Toh WS; Yi YW; Witwer KW; Giebel B; Lim SK
    Cytotherapy; 2021 May; 23(5):373-380. PubMed ID: 33934807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD73 activity of mesenchymal stromal cell-derived extracellular vesicle preparations is detergent-resistant and does not correlate with immunomodulatory capabilities.
    Bauer FN; Tertel T; Stambouli O; Wang C; Dittrich R; Staubach S; Börger V; Hermann DM; Brandau S; Giebel B
    Cytotherapy; 2023 Feb; 25(2):138-147. PubMed ID: 36244910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications.
    Witwer KW; Van Balkom BWM; Bruno S; Choo A; Dominici M; Gimona M; Hill AF; De Kleijn D; Koh M; Lai RC; Mitsialis SA; Ortiz LA; Rohde E; Asada T; Toh WS; Weiss DJ; Zheng L; Giebel B; Lim SK
    J Extracell Vesicles; 2019; 8(1):1609206. PubMed ID: 31069028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils.
    Wang C; Börger V; Sardari M; Murke F; Skuljec J; Pul R; Hagemann N; Dzyubenko E; Dittrich R; Gregorius J; Hasenberg M; Kleinschnitz C; Popa-Wagner A; Doeppner TR; Gunzer M; Giebel B; Hermann DM
    Stroke; 2020 Jun; 51(6):1825-1834. PubMed ID: 32312217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demystifying the long noncoding RNA landscape of small EVs derived from human mesenchymal stromal cells.
    Lee CW; Chen YF; Hsiao AW; Wang AY; Shen OY; Wang BY; Ho LWC; Lin WT; Choi CHJ; Lee OK
    J Adv Res; 2022 Jul; 39():73-88. PubMed ID: 35777918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor.
    Jakl V; Ehmele M; Winkelmann M; Ehrenberg S; Eiseler T; Friemert B; Rojewski MT; Schrezenmeier H
    Front Bioeng Biotechnol; 2023; 11():1107055. PubMed ID: 36761296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Role of microRNAs of Small Extracellular Vesicles from Human Mesenchymal Stromal/Stem Cells in Treatment of Experimental Traumatic Brain Injury.
    Zhang Y; Zhang Y; Chopp M; Pang H; Chen L; Zhang ZG; Mahmood A; Xiong Y
    J Neurotrauma; 2023 Apr; 40(7-8):758-771. PubMed ID: 36394949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Tumorigenic Potential in Mesenchymal-Stem/Stromal-Cell-Derived Small Extracellular Vesicles (MSC-sEV).
    Tan TT; Lai RC; Padmanabhan J; Sim WK; Choo ABH; Lim SK
    Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33918628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent human mesenchymal stromal cell-derived extracellular vesicle preparations differentially attenuate symptoms in an advanced murine graft-versus-host disease model.
    Madel RJ; Börger V; Dittrich R; Bremer M; Tertel T; Phuong NNT; Baba HA; Kordelas L; Staubach S; Stein F; Haberkant P; Hackl M; Grillari R; Grillari J; Buer J; Horn PA; Westendorf AM; Brandau S; Kirschning CJ; Giebel B
    Cytotherapy; 2023 Aug; 25(8):821-836. PubMed ID: 37055321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical considerations in transforming MSC therapy for neurological diseases from cell to EV.
    Tan TT; Toh WS; Lai RC; Lim SK
    Exp Neurol; 2022 Mar; 349():113953. PubMed ID: 34921846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo.
    Cheng A; Choi D; Lora M; Shum-Tim D; Rak J; Colmegna I
    Stem Cell Res Ther; 2020 Dec; 11(1):539. PubMed ID: 33317598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
    Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
    Front Immunol; 2018; 9():2538. PubMed ID: 30473695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaled Isolation of Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles.
    Börger V; Staubach S; Dittrich R; Stambouli O; Giebel B
    Curr Protoc Stem Cell Biol; 2020 Dec; 55(1):e128. PubMed ID: 32956560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD10-Bound Human Mesenchymal Stem/Stromal Cell-Derived Small Extracellular Vesicles Possess Immunomodulatory Cargo and Maintain Cartilage Homeostasis under Inflammatory Conditions.
    Kouroupis D; Kaplan LD; Huard J; Best TM
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Extracellular Vesicles Maintain Homeostasis of Senescent Mesenchymal Stem Cells at Least Through Excreting Harmful Lipids.
    Wang L; Zhang H; Xiao X; Wang S; Zhao RC
    Stem Cells Dev; 2023 Sep; 32(17-18):565-579. PubMed ID: 37262010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia.
    Ophelders DR; Wolfs TG; Jellema RK; Zwanenburg A; Andriessen P; Delhaas T; Ludwig AK; Radtke S; Peters V; Janssen L; Giebel B; Kramer BW
    Stem Cells Transl Med; 2016 Jun; 5(6):754-63. PubMed ID: 27160705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells and their small extracellular vesicles in allergic diseases: From immunomodulation to therapy.
    Peng YQ; Deng XH; Xu ZB; Wu ZC; Fu QL
    Eur J Immunol; 2023 Oct; 53(10):e2149510. PubMed ID: 37572379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells mediated by small extracellular vesicles derived from MSCs attenuated the ILC2 activity via PGE2 in patients with allergic rhinitis.
    Liu XQ; Peng YQ; Huang LX; Li CG; Kuang PP; Chen DH; Wu ZC; He BX; Zhou ZR; Fu QL
    Stem Cell Res Ther; 2023 Jul; 14(1):180. PubMed ID: 37488601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease.
    Dal Collo G; Adamo A; Gatti A; Tamellini E; Bazzoni R; Takam Kamga P; Tecchio C; Quaglia FM; Krampera M
    Stem Cells; 2020 May; 38(5):698-711. PubMed ID: 32064745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
    Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T
    Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.